The Defense Health Agency has awarded a $760,844.00 Project Grant to the Texas A&M University System Health Science Center to conduct research under the Military Medical Research and Development program (CFDA 12.420). The three-year grant, awarded on September 15, 2023 with a completion date of September 14, 2026, will fund research titled "Targeting the MIF/CD74 Immune Axis to Treat GWI Astrocyte, Neuronal, and Cognitive Dysfunction." This research aims to investigate medical solutions for the battlefield and transform healthcare for service members and the public through innovative and impactful biomedical research. The Texas A&M University System Health Science Center has a history of successfully conducting federal grant and contract work in areas such as Gulf War Illness, spinal cord injuries, infectious diseases, and cancer therapies.
Generated 5/14/24, 4:48 AM